Study of Endothelial Protective Activity of Phenol-Derived Thrombin and Arginase-2 Inhibitors KUD-259 and KUD-974

M. V. Pokrovskii; M. V. Korokin; K. V. Kudryavtsev; T. G. Pokrovskaya; O. S. Gudyrev; V. V. Gureev; L. V. Korokina; S. V. Povetkin

doi:10.1007/s10517-017-3822-y

Study of Endothelial Protective Activity of Phenol-Derived Thrombin and Arginase-2 Inhibitors KUD-259 and KUD-974

Authors: Pokrovskii M.V.¹, Korokin M.V.¹, Kudryavtsev K.V.¹, Pokrovskaya T.G.¹, Gudyrev O.S.¹, Gureev V.V.¹, Korokina L.V.¹, Povetkin S.V.¹
Affiliations:
1. Department of Pharmacology, Medical School, Belgorod State University
Issue: Vol 163, No 4 (2017)
Pages: 436-438
Section: Article
URL: https://journals.rcsi.science/0007-4888/article/view/238968
DOI: https://doi.org/10.1007/s10517-017-3822-y
ID: 238968

Cite item

Full Text

Open Access
Restricted Access

Access granted
Restricted Access

Subscription Access

Abstract
About the authors
References
Statistics

Abstract

We performed correction of endothelial dysfunction with phenol derivatives KUD-259 and KUD-974 containing heteroatomic and heterocyclic structures. Pharmacological activity of KUD-259 and KUD-974 surpassed that of L-norvaline, a non-selective arginase inhibitor.